CG
DMTK

Carmignac Gestion’s DermTech, Inc. Common Stock DMTK Stock Holding History

Carmignac Gestion’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-588,647
Closed -$9.31M – 136
2021
Q4 		$9.31M Buy
588,647
+205,373
+54% +$4.93M 0.13% 67
2021
Q3 		$12.4M Sell
383,274
-400
-0.1% -$14.1K 0.15% 61
2021
Q2 		$15.9M Buy
383,674
+79,860
+26% +$3.28M 0.18% 57
2021
Q1 		$15.5M Buy
+303,814
New +$15.9M 0.18% 58

Other funds holding DMTK

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Carmignac Gestion's DMTK Position: Q1 2022 in Review

Carmignac Gestion sold out of DermTech, Inc. Common Stock (DMTK) in Q1 2022, closing a stake of 588,647 shares — an estimated $9.31M sold.

Carmignac Gestion first reported a position in DMTK in Q1 2021 and held it in 4 quarters. The position peaked at $15.9M in Q2 2021. 152 funds tracked by Wall St. Rank hold DMTK as of Q1 2022.

  • Carmignac Gestion reported no remaining DermTech, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Carmignac Gestion sold 588,647 DermTech, Inc. Common Stock shares in Q1 2022, an estimated $9.31M.
  • Carmignac Gestion first reported a position in DermTech, Inc. Common Stock in Q1 2021 and held it in 4 quarters.
  • Carmignac Gestion's DermTech, Inc. Common Stock position peaked at $15.9M in Q2 2021.
  • 152 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q1 2022.

Based on Carmignac Gestion's 13F filing for Q1 2022, filed 13 May 2022.